You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

METHERGINE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Methergine patents expire, and when can generic versions of Methergine launch?

Methergine is a drug marketed by Edison Theraps Llc and is included in one NDA.

The generic ingredient in METHERGINE is methylergonovine maleate. There is one drug master file entry for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the methylergonovine maleate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Methergine

A generic version of METHERGINE was approved as methylergonovine maleate by AM REGENT on November 24th, 2008.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for METHERGINE?
  • What are the global sales for METHERGINE?
  • What is Average Wholesale Price for METHERGINE?
Summary for METHERGINE
US Patents:0
Applicants:1
NDAs:1
Raw Ingredient (Bulk) Api Vendors: 75
Clinical Trials: 9
Patent Applications: 1,535
Drug Prices: Drug price information for METHERGINE
What excipients (inactive ingredients) are in METHERGINE?METHERGINE excipients list
DailyMed Link:METHERGINE at DailyMed
Drug patent expirations by year for METHERGINE
Drug Prices for METHERGINE

See drug prices for METHERGINE

Recent Clinical Trials for METHERGINE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Columbia UniversityPhase 4
Stony Brook UniversityPhase 3
Johns Hopkins UniversityEarly Phase 1

See all METHERGINE clinical trials

US Patents and Regulatory Information for METHERGINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Edison Theraps Llc METHERGINE methylergonovine maleate INJECTABLE;INJECTION 006035-004 Approved Prior to Jan 1, 1982 AP RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Edison Theraps Llc METHERGINE methylergonovine maleate TABLET;ORAL 006035-003 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.